The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques

<p>Abstract</p> <p>Background</p> <p>Our research compared whole pelvic (WP) and prostate-only (PO) 3-dimensional conformal radiotherapy (3DCRT) techniques in terms of the incidence and evolution of acute and late toxicity of the rectum and urinary bladder, and identifi...

Full description

Bibliographic Details
Main Authors: Starec Miroslav, Richter Jan, Vinakurau Stepan, Vranova Jana, Fiserova Anna, Rosina Jozef
Format: Article
Language:English
Published: BMC 2011-07-01
Series:Radiation Oncology
Subjects:
Online Access:http://www.ro-journal.com/content/6/1/87
id doaj-dcc11b1e8cd04567bc39cf19332f9272
record_format Article
spelling doaj-dcc11b1e8cd04567bc39cf19332f92722020-11-25T00:52:16ZengBMCRadiation Oncology1748-717X2011-07-01618710.1186/1748-717X-6-87The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniquesStarec MiroslavRichter JanVinakurau StepanVranova JanaFiserova AnnaRosina Jozef<p>Abstract</p> <p>Background</p> <p>Our research compared whole pelvic (WP) and prostate-only (PO) 3-dimensional conformal radiotherapy (3DCRT) techniques in terms of the incidence and evolution of acute and late toxicity of the rectum and urinary bladder, and identified the PTV-parameters influencing these damages and changes in antitumor immune response.</p> <p>Methods</p> <p>We analyzed 197 prostate cancer patients undergoing 3DCRT for gastrointestinal (GI) and genitourinary (GU) toxicities, and conducted a pilot immunological study including flow cytometry and an NK cell cytotoxicity assay. Acute and late toxicities were recorded according to the RTOG and the LENT-SOMA scales, respectively. Univariate and multivariate analyses were conducted for factors associated with toxicity.</p> <p>Results</p> <p>In the WP group, an increase of acute rectal toxicity was observed. A higher incidence of late GI/GU toxicity appeared in the PO group. Only 18 patients (WP-7.76% and PO-11.11%) suffered severe late GI toxicity, and 26 patients (WP-11.21% and PO-16.05%) severe late GU toxicity. In the majority of acute toxicity suffering patients, the diminution of late GI/GU toxicity to grade 1 or to no toxicity after radiotherapy was observed. The 3DCRT technique itself, patient age, T stage of TNM classification, surgical intervention, and some dose-volume parameters emerged as important factors in the probability of developing acute and late GI/GU toxicity. The proportion and differentiation of NK cells positively correlated during 3DCRT and negatively so after its completion with dose-volumes of the rectum and urinary bladder. T and NKT cells were down-regulated throughout the whole period. We found a negative correlation between leukocyte numbers and bone marrow irradiated by 44-54 Gy and a positive one for NK cell proportion and doses of 5-25 Gy. The acute GU, late GU, and GI toxicities up-regulated the T cell (CTL) numbers and NK cytotoxicity.</p> <p>Conclusion</p> <p>Our study demonstrates the association of acute and late damage of the urinary bladder and rectum, with clinical and treatment related factors. The 3DCRT itself does not induce the late GI or GU toxicity and rather reduces the risk of transition from acute to late toxicity. We have described for the first time the correlation between organs at risk, dose-volume parameters, and the immunological profile.</p> http://www.ro-journal.com/content/6/1/873-dimensional conformal radiotherapy (3DCRT)gastrointestinal and genitourinary toxicityprostate cancerNK cellsPTV parameterspelvic bone marrow
collection DOAJ
language English
format Article
sources DOAJ
author Starec Miroslav
Richter Jan
Vinakurau Stepan
Vranova Jana
Fiserova Anna
Rosina Jozef
spellingShingle Starec Miroslav
Richter Jan
Vinakurau Stepan
Vranova Jana
Fiserova Anna
Rosina Jozef
The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
Radiation Oncology
3-dimensional conformal radiotherapy (3DCRT)
gastrointestinal and genitourinary toxicity
prostate cancer
NK cells
PTV parameters
pelvic bone marrow
author_facet Starec Miroslav
Richter Jan
Vinakurau Stepan
Vranova Jana
Fiserova Anna
Rosina Jozef
author_sort Starec Miroslav
title The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
title_short The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
title_full The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
title_fullStr The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
title_full_unstemmed The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
title_sort evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques
publisher BMC
series Radiation Oncology
issn 1748-717X
publishDate 2011-07-01
description <p>Abstract</p> <p>Background</p> <p>Our research compared whole pelvic (WP) and prostate-only (PO) 3-dimensional conformal radiotherapy (3DCRT) techniques in terms of the incidence and evolution of acute and late toxicity of the rectum and urinary bladder, and identified the PTV-parameters influencing these damages and changes in antitumor immune response.</p> <p>Methods</p> <p>We analyzed 197 prostate cancer patients undergoing 3DCRT for gastrointestinal (GI) and genitourinary (GU) toxicities, and conducted a pilot immunological study including flow cytometry and an NK cell cytotoxicity assay. Acute and late toxicities were recorded according to the RTOG and the LENT-SOMA scales, respectively. Univariate and multivariate analyses were conducted for factors associated with toxicity.</p> <p>Results</p> <p>In the WP group, an increase of acute rectal toxicity was observed. A higher incidence of late GI/GU toxicity appeared in the PO group. Only 18 patients (WP-7.76% and PO-11.11%) suffered severe late GI toxicity, and 26 patients (WP-11.21% and PO-16.05%) severe late GU toxicity. In the majority of acute toxicity suffering patients, the diminution of late GI/GU toxicity to grade 1 or to no toxicity after radiotherapy was observed. The 3DCRT technique itself, patient age, T stage of TNM classification, surgical intervention, and some dose-volume parameters emerged as important factors in the probability of developing acute and late GI/GU toxicity. The proportion and differentiation of NK cells positively correlated during 3DCRT and negatively so after its completion with dose-volumes of the rectum and urinary bladder. T and NKT cells were down-regulated throughout the whole period. We found a negative correlation between leukocyte numbers and bone marrow irradiated by 44-54 Gy and a positive one for NK cell proportion and doses of 5-25 Gy. The acute GU, late GU, and GI toxicities up-regulated the T cell (CTL) numbers and NK cytotoxicity.</p> <p>Conclusion</p> <p>Our study demonstrates the association of acute and late damage of the urinary bladder and rectum, with clinical and treatment related factors. The 3DCRT itself does not induce the late GI or GU toxicity and rather reduces the risk of transition from acute to late toxicity. We have described for the first time the correlation between organs at risk, dose-volume parameters, and the immunological profile.</p>
topic 3-dimensional conformal radiotherapy (3DCRT)
gastrointestinal and genitourinary toxicity
prostate cancer
NK cells
PTV parameters
pelvic bone marrow
url http://www.ro-journal.com/content/6/1/87
work_keys_str_mv AT starecmiroslav theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT richterjan theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT vinakuraustepan theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT vranovajana theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT fiserovaanna theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT rosinajozef theevolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT starecmiroslav evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT richterjan evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT vinakuraustepan evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT vranovajana evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT fiserovaanna evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
AT rosinajozef evolutionofrectalandurinarytoxicityandimmuneresponseinprostatecancerpatientstreatedwithtwothreedimensionalconformalradiotherapytechniques
_version_ 1725243198891098112